|
ZIOPHARM Oncology, Inc. is a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs.
We apply new insights from molecular and cancer biology to understand the efficacy and safety limitations of approved and developmental cancer therapies and identify proprietary and related molecules for better patient treatment.
Recent Releases
May 13, 2008
ZIOPHARM Receives Notices of Allowance for Two U.S. Patent Applications Covering Darinaparsin
May 12, 2008
ZIOPHARM Oncology Reports First Quarter Results
more »
Events
Apr 23, 2008
ZIOPHARM 2008 Annual Meeting
Apr 3, 2008
FORTIS Biotech Conference
more »
| 
